| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A-R | USD | 403.300 | 5.06 | - | AAA | - | - | - | 42.03% | - | Floating | 3mL | - | 153 | 3mL+153 | - | 100.00000 |
| A-Loan | USD | 30.000 | 5.06 | - | AAA | - | - | - | 42.03% | - | Floating | 3mL | - | 153 | 3mL+153 | - | 100.00000 |
| B-R | USD | 74.750 | 6.95 | - | AA | - | - | - | 32.03% | - | Floating | 3mL | - | 190 | 3mL+190 | - | 100.00000 |
| C-R | USD | 59.800 | 7.34 | - | A | - | - | - | 24.03% | - | Floating | 3mL | - | 260 | 3mL+260 | - | 100.00000 |
| D-R | USD | 44.850 | 7.74 | - | BBB- | - | - | - | 18.03% | - | Floating | 3mL | - | 385 | 3mL+385 | - | 100.00000 |
| Equity | USD | 135.345 | - | - | NR | - | - | - | - | - | - | - | - | - | - | - | - |
Explore all other research.